{
  "id": 3023263,
  "title": "Biogen: LEQEMBI IQLIK Autoinjector Available In U.S. For Early Alzheimer's",
  "url": "https://urgent.news/2026/08/24/biogen-leqembi-iqlik-autoinjector-available-in-u-s-for-early",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-24T12:21:38.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/biogen-leqembi-iqlik-autoinjector-available-us-early-alzheimers"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Eisai Co. (4523.T, EII.SG) and Biogen (BIIB) announced that once weekly lecanemab-irmb subcutaneous injection - LEQEMBI IQLIK - is now available in the U.S. for initiation therapy for early Alzheimer's disease in adults with mild cognitive impairment or mild dementia",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}